SSX mRNA expression in gynecological cancers.
Endometrial cancer
Ovarian cancer
Cervical cancer
SSX1
1/50 (2%)
0/40 (0%)
1/25 (4%)
SSX2
2/50 (4%)
1/40 (3%)
SSX4
12/50 (24%)
5/40 (13%)
5/25 (20%)
Copyright © 2004 by Eiichi Nakayama